Basic Information
Basic information for AL022068.1-211-32aa
Peptide Name AL022068.1-211-32aa
Genome Position chr6:19803680-19803754,19804257-19804277[-]
Species Human
Peptide Sequence MDKSFQKISCFKTAAFLEESPQLTTKQNPPGG
Peptide Length 32
Unique No (AL022068.1-209-32aa,AL022068.1-212-32aa,AL022068.1-208-32aa,AL022068.1-220-32aa)
Grand Average of Hydropathicity -0.6781
Relative Molecular Mass 4088.6
Experimental Evidences no
lncRNA ID/Name ENSG00000228412;AL022068.1
Transcript ID/Name ENST00000606628;AL022068.1-211
Transcript Length 416
Coding Ability 0.5721
DNA Sequence Corresponding to Peptide ATGGATAAATCTTTCCAGAAGATTTCTTGCTTCAAAACAGCTGCATTTTTGGAAGAAAGTCCACAACTGACAACTAAGCAAAACCCTCCTGGTGGA
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :